C Reactive protein and its relation to cardiovascular risk factors: A population based cross sectional study

British Medical Journal

Volumn 312, Issue 7038, 1996, Pages 1061-1065

  Mendall, M A ^a   Patel, Praful ^a   Ballam, Lydia ^a   Strachan, D ^a   Northfield, T C ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; C REACTIVE PROTEIN; CHOLESTEROL; FIBRINOGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIALIC ACID; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ARTICLE; ATHEROSCLEROSIS; BACTERIAL INFECTION; BODY MASS; CARDIOVASCULAR DISEASE; CHLAMYDOPHILA PNEUMONIAE; CHOLESTEROL BLOOD LEVEL; CHRONIC BRONCHITIS; CORONARY RISK; DISEASE COURSE; ELECTROCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBRINOGEN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HELICOBACTER PYLORI; HUMAN; INFECTION; INFLAMMATION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0029866045     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.312.7038.1061     Document Type: Article

References (27)

1. Fahie-Wilson M, Mills R, Wilson K. HDL cholesterol and the acute phase reaction following myocardial infarction and acute pancreatitis. Clin Chim Acta 1987;167:197-209.
2. Alvarez C, Ramos A. Lipids, lipoproteins and apoproteins in serum during infection. Clin Chem 1986;32:142-5.
3. Heldenburg D, Rubinstein O, Levtov L, Berns B, Werbin B, Tamir I. Serum lipids and lipoprotein concentrations during acute phase of myocardial infarction. Atherosclerosis 1980;35:433-7.
4. Ryder R, Hayes T, Mulligan I, Kingswood J, Williams S, Owens D. How soon after myocardial infarction should plasma lipids be assessed? BMJ 1984;289:1651-2.
5. Coombes E, Shakespeare P, Batstone F. Lipoprotein changes after burn injury in man. J Trauma 1980;20:971-5.
6. Cabana V, Siegel J, Sabesin S. Effects of the acute phase response on the concentration and density distribution of plasma lipids and apolipoproteins. J Lipid Res 1989;30:39-49.
7. Lindberg G, Eklund GA, Gullberg B, Rastam L. Serum sialic acid concentration and cardiovascular mortality. BMJ 1991;302:143-6.
8. Steel D, Whitehead A. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today 1994;15:81-8.
9. Palosuo T, Husman T, Koistinen J, Aho K. C-reactive protein in population samples. Acta Medica Scandinavica 1986;220:175-9.
10. De Beer F, Pepys M. Solid-phase immunoradiometric assay for C-reactive protein using magnetisable cellulose particles. J Immunol Methods 1982;50:299-308.
11. Patel P, Mendall MA, Carrington D, Strachan D, Leatham E, Molineaux N, et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ 1995;311:711-4.
12. Mattila KJ, Nieminen MS, Valtonen VV. Association between dental health and acute myocardial infarction. BMJ 1989;298:779-82.
13. Mendall M, Goggin P, Levy J, Molineaux N, Strachan D, Camm A, et al. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 1994;71:437-9.
14. Saikku P, Leiononen M, Tenkanen L, Linnanmaki E, Ekman M, Manninen M, et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki heart study. Ann Intern Med 1992;116:273-7.
15. Woodhouse P, Khaw K, Plummer M, Foley A, Meade T. Seasonal variations of plasma fibrinogen and factor VII activity in the elderly: winter infections and death from cardiovascular disease. Lancet 1994;343:435-9.
16. Juhan-Vagye I, Thompson S, Jespersen J. Involvement of the hemostatic system in the insulin resistance syndrome. Arterioscler Thromb 1993;13:1865-73.
17. Liuzzo G, Luigi M, Biasucci L, Pepys M. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994;331:417-24.
18. Thompson S, Kienast J, Pyke S, Heverkate F, Van de Loo J. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 1995;332:635-41.
19. Gauldie J, Richards C, Northemann W, Fey G, Baumann H. IFNB2/BSF2/ IL-6 is the monocyte-derived HSF that regulates receptor-specific acute phase gene regulation in hepatocytes. Ann NY Acad Sci 1989;557:46-59.
20. Mackiewicz A, Speroff T, Ganapathim M, Kuschner I. Effects of cytokine combinations on acute phase protein production in two human hepatoma cell lines. J Immunol 1991;146:3032-7.
21. Baumann H, Gauldie J. The acute phase response. Immunol Today 1994;15:74-80.
22. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 1995;95:2409-15.
23. Naito H. Serum apolipoprotein measurements: an improved discriminator for assessing coronary heart disease. Compr Ther 1987;13:43-52.
24. Feingold K, Grunfeld C. Role of cytokines in inducing hyperlipidemia. Diabetes 1992;41(suppl 2):97-101.
25. Akira A, Taga T, Kishimoto T. Interleukin-6 in biology and medicine. Adv Immunol 1993;54:1-78.
26. Kahn C. Causes of insulin resistance. Science 1995;373:384-5.
27. Reaven G. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607.